Boston Partners’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
OAG
GIM
Boston Partners's STE Position: Q2 2026 in Review
Boston Partners increased its Steris (STE) stake by 74% in Q2 2026, buying an estimated $136M and bringing the position to 1,498,334 shares worth $315M. The position accounts for 0.28% of the portfolio, ranked #121.
Boston Partners first reported a position in STE in Q3 2025 and has held it in 4 quarters since. 833 funds tracked by Wall St. Rank hold STE as of Q2 2026.
- Boston Partners held 1,498,334 shares of Steris worth $315M as of Q2 2026.
- Boston Partners bought 636,081 Steris shares in Q2 2026, an estimated $136M.
- Steris made up 0.28% of Boston Partners's portfolio in Q2 2026, its #121 holding.
- Boston Partners first reported a position in Steris in Q3 2025 and has held it in 4 quarters since.
- 833 funds tracked by Wall St. Rank held Steris as of Q2 2026.
Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.